Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Geographic Risk of General and Abdominal Obesity and Related Determinants in Iranian Children and Adolescents: Caspian-Iv Study; [Risque Geographique Lie a L’Obesite Generale Et Abdominale Et Ses Facteurs Determinants Chez Les Enfants Et Les Adolescents Iraniens: L’Etude Caspian-Iv]
Sadaf Ghajarieh Sepanlou
Sadaf Ghajarieh Sepanlou

Associate Professor of Epidemiology

Digestive Diseases Research Center

Tehran University of Medical Sciences

All Documents
1. Burden of 292 Causes of Death and Life Expectancy Decomposition in Iran, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet Global Health (2026)
2. Burden of 292 Causes of Death and Life Expectancy Decomposition in Iran, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet Global Health (2026)
3. Comparison of Prevalence of Fatty Liver Disease According to the Different Nomenclatures of Nafld, Mafld, and Masld in a Large Iranian Population-Based Study, Scientific Reports (2026)
4. Global, Regional and National Burden of Ischemic Heart Disease Attributable to Suboptimal Diet, 1990–2023: A Global Burden of Disease Study, Nature Medicine (2026)
5. Global, Regional and National Burden of Ischemic Heart Disease Attributable to Suboptimal Diet, 1990–2023: A Global Burden of Disease Study, Nature Medicine (2026)
6. Obesity Rise Plateaus in Developed Nations and Accelerates in Developing Nations, Nature (2026)
7. Obesity Rise Plateaus in Developed Nations and Accelerates in Developing Nations, Nature (2026)
8. Association Between Prediagnostic Risk Factors and Survival After Colorectal Cancer Diagnosis in Golesten Cohort Study, Scientific Reports (2025)
9. Burden of 375 Diseases and Injuries, Risk-Attributable Burden of 88 Risk Factors, and Healthy Life Expectancy in 204 Countries and Territories, Including 660 Subnational Locations, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
10. Burden of 375 Diseases and Injuries, Risk-Attributable Burden of 88 Risk Factors, and Healthy Life Expectancy in 204 Countries and Territories, Including 660 Subnational Locations, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
11. Efficacy of N-Acetylcysteine in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-Analysis, BMC Gastroenterology (2025)
12. Global Age-Sex-Specific All-Cause Mortality and Life Expectancy Estimates for 204 Countries and Territories and 660 Subnational Locations, 1950–2023: A Demographic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
13. Global Age-Sex-Specific All-Cause Mortality and Life Expectancy Estimates for 204 Countries and Territories and 660 Subnational Locations, 1950–2023: A Demographic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
14. Global Burden of 292 Causes of Death in 204 Countries and Territories and 660 Subnational Locations, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
15. Global Burden of 292 Causes of Death in 204 Countries and Territories and 660 Subnational Locations, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023, The Lancet (2025)
16. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023, Journal of the American College of Cardiology (2025)
17. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023, Journal of the American College of Cardiology (2025)
18. Impact of Smoking and Opium Cessation on Gastrointestinal Cancer Risk: A 15-Year Longitudinal Study in Golestan Cohort, Scientific Reports (2025)
19. Octreotide and Somatostatin As Prophylactic Agents Against Postendoscopic Retrograde Cholangiopancreatography Pancreatitis an Updated Comprehensive Systematic Review and Meta-Analysis, Journal of Clinical Gastroenterology (2025)
20. Population Attributable Fraction of Dietary Risk Factors for Cancer Mortality With a Focus on Gastrointestinal Cancers in a Population Based Cohort Study, Scientific Reports (2025)
21. Pre-Diagnostic Risk Factors for Brain Cancer Incidence and Survival: Insights From the Golestan Cohort Study, BMC Cancer (2025)
22. Reducing Premature Mortality From Cardiovascular Diseases in Low and Middle Income Countries: The Role of Polypill in Public Health Policy, International Journal of Cardiology: Cardiovascular Risk and Prevention (2025)
23. Stepwise Approach to Screen High-Risk Individuals Using the Non-Laboratory-Based and Laboratory-Based Cvd Risk Scoring, Journal of Public Health (2025)
24. Survival Assessment and Pre-Diagnostic Risk Factors for Lung Cancer Incidence: Insights From the Golestan Cohort Study, PLoS ONE (2025)
25. A Quick and Sensitive Lc-Ms/Ms Method for Simultaneous Quantification of Sofosbuvir Metabolite (Gs-331007) in Human Plasma: Application to Hepatitis C Infected Patients With End-Stage Renal Disease, Middle East Journal of Digestive Diseases (2024)
26. Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prediction of Prognosis of Colorectal Cancer; [و پیش بینی پیش آگهی سرطان کولورکتال کاربرد هوش مصنوعی در غربالگری، تشخیص، درمان،], Govaresh (2024)
27. Causes and Predictors of Premature Death in the Pars Cohort Study, Iran: A Cohort Study, BMC Public Health (2024)
28. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Disease: A Pragmatic Cluster-Randomised Controlled Trial (Polypars), Heart (2024)
29. Forecasting the Effects of Smoking Prevalence Scenarios on Years of Life Lost and Life Expectancy From 2022 to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Public Health (2024)
30. Forecasting the Effects of Smoking Prevalence Scenarios on Years of Life Lost and Life Expectancy From 2022 to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Public Health (2024)
31. General and Abdominal Adiposity and Hypertension in Eight World Regions: A Pooled Analysis of 837 Population-Based Studies With 7·5 Million Participants, The Lancet (2024)
32. General and Abdominal Adiposity and Hypertension in Eight World Regions: A Pooled Analysis of 837 Population-Based Studies With 7·5 Million Participants, The Lancet (2024)
33. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
34. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
35. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
36. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
37. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
38. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
39. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
40. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
41. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
42. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
43. National-Level and State-Level Prevalence of Overweight and Obesity Among Children, Adolescents, and Adults in the Usa, 1990–2021, and Forecasts up to 2050, The Lancet (2024)
44. National-Level and State-Level Prevalence of Overweight and Obesity Among Children, Adolescents, and Adults in the Usa, 1990–2021, and Forecasts up to 2050, The Lancet (2024)
45. Population Attributable Fractions of Cancer Mortality Related to Indoor Air Pollution, Animal Contact, and Water Source As Environmental Risk Factors: Findings From the Golestan Cohort Study, PLoS ONE (2024)
46. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
47. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
48. The Contribution of Metabolic Risk Factors to Cardiovascular Mortality in Golestan Cohort Study: Population Attributable Fraction Estimation, International Journal of Cardiology: Cardiovascular Risk and Prevention (2024)
49. Association of Indoor Use of Pesticides With Ckd of Unknown Origin, PLoS ONE (2023)
50. Diet Quality and Subsequent Incidence of Upper Gastrointestinal Cancers: Results From the Golestan Cohort Study, Archives of Iranian Medicine (2023)
51. Diminishing Benefits of Urban Living for Children and Adolescents’ Growth and Development, Nature (2023)
52. Diminishing Benefits of Urban Living for Children and Adolescents’ Growth and Development, Nature (2023)
53. Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in Ckd: An Individual Participant Data Meta-Analysis, Clinical journal of the American Society of Nephrology : CJASN (2023)
54. Global Burden of Cardiovascular Diseases and Risks, 1990-2022, Journal of the American College of Cardiology (2023)
55. Global Burden of Peripheral Artery Disease and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Global Health (2023)
56. Global Burden of Peripheral Artery Disease and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Global Health (2023)
57. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality., New England Journal of Medicine (2023)
58. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
59. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
60. Global Variation in Diabetes Diagnosis and Prevalence Based on Fasting Glucose and Hemoglobin A1c, Nature Medicine (2023)
61. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
62. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
63. Global, Regional, and National Burden of Low Back Pain, 1990–2020, Its Attributable Risk Factors, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
64. Global, Regional, and National Burden of Low Back Pain, 1990–2020, Its Attributable Risk Factors, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
65. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
66. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
67. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
68. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
69. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results, Journal of Diabetes and Metabolic Disorders (2023)
70. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results, Journal of Diabetes and Metabolic Disorders (2023)
71. The Levels and Trends of Diabetes Prevalence at National and Sub-National Levels in Iran (1990 – 2016), Journal of Diabetes and Metabolic Disorders (2023)
72. Universal Research Index: An Inclusive Metric to Quantify Scientific Research Output, Journal of Academic Librarianship (2023)
73. A Response to the Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data From Persian Cohort Study” to the End of Study, Diabetes Therapy (2022)
74. An Office-Based Cardiovascular Prediction Model Developed and Validated in Cohort Studies of a Middle-Income Country, Journal of Clinical Epidemiology (2022)
75. An Office-Based Cardiovascular Prediction Model Developed and Validated in Cohort Studies of a Middle-Income Country, Journal of Clinical Epidemiology (2022)
76. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
77. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
78. Comparison of Laboratory-Based and Non-Laboratory-Based Who Cardiovascular Disease Risk Charts: A Population-Based Study, Journal of Translational Medicine (2022)
79. Correction To: A Response to the Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data From Persian Cohort Study” (Diabetes Therapy, (2022), 13, 1, (221-224), 10.1007/S13300-021-01187-8), Diabetes Therapy (2022)
80. Dietary Acid Load and Mortality From All Causes, Cvd and Cancer: Results From the Golestan Cohort Study, British Journal of Nutrition (2022)
81. Estimates, Trends, and Drivers of the Global Burden of Type 2 Diabetes Attributable to Pm2·5 Air Pollution, 1990–2019: An Analysis of Data From the Global Burden of Disease Study 2019, The Lancet Planetary Health (2022)
82. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
83. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
84. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
85. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
86. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
87. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
88. Iran's Burden of Disease and Burden of Data Collection – Authors' Reply, The Lancet (2022)
89. Level and Trend of Total Plasma Cholesterol in National and Subnational of Iran: A Systematic Review and Age-Spatio-Temporal Analysis From 1990 to 2016, Journal of Diabetes and Metabolic Disorders (2022)
90. Levels and Trends of Maternal Mortality and Morbidity by Cause in North Africa and Middle East, 1990 to 2019: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
91. Mapping Development and Health Effects of Cooking With Solid Fuels in Low-Income and Middle-Income Countries, 2000–18: A Geospatial Modelling Study, The Lancet Global Health (2022)
92. Maternal Mortality and Morbidity by Cause in Provinces of Iran, 1990 to 2019: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
93. Neonate, Infant, and Child Mortality by Cause in Provinces of Iran: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
94. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
95. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
96. Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies, International journal of clinical practice (2022)
97. Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies, International journal of clinical practice (2022)
98. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran, International Journal of Health Policy and Management (2022)
99. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran, International Journal of Health Policy and Management (2022)
100. Prevalence and Predictors of Low Back Pain Among the Iranian Population: Results From the Persian Cohort Study, Annals of Medicine and Surgery (2022)
101. Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study, Scientific Reports (2022)
102. Socioeconomic Inequalities in Prevalence, Awareness, Treatment and Control of Hypertension: Evidence From the Persian Cohort Study, BMC Public Health (2022)
103. Spatial Environmental Factors Predict Cardiovascular and All-Cause Mortality: Results of the Space Study, PLoS ONE (2022)
104. The Association of Dietary Intake and Plasma Fatty Acid Panel in Pancreatic Cancer Patients: Results From Golestan Cohort Study, Nutrition and Health (2022)
105. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
106. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
107. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
108. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
109. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
110. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
111. An Updated Systematic Review and Metaanalysis on Efficacy of Sofosbuvir in Treating Hepatitis C-Infected Patients With Advanced Chronic Kidney Disease, PLoS ONE (2021)
112. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
113. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
114. Burden of Transport-Related Injuries in the Eastern Mediterranean Region: A Systematic Analysis for the Global Burden of Disease Study 2017, Archives of Iranian Medicine (2021)
115. Circulating Plasma Fatty Acids and Risk of Pancreatic Cancer: Results From the Golestan Cohort Study, Clinical Nutrition (2021)
116. Correction To: Impact of 2017 Acc/Aha Guideline on Prevalence, Awareness, Treatment, Control, and Determinants of Hypertension: A Population-Based Cross-Sectional Study in Southwest of Iran (Population Health Metrics, (2021), 19, 1, (26), 10.1186/S12963-021-00260-5), Population Health Metrics (2021)
117. Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: Golestan Cohort Study, Nutrition Journal (2021)
118. Dietary Quality Using Four Dietary Indices and Lung Cancer Risk: The Golestan Cohort Study (Gcs), Cancer Causes and Control (2021)
119. Erratum: Effectiveness of Polypill for Prevention of Cardiovascular Disease (Polypars): Protocol of a Randomized Controlled Trial (Archives of Iranian Medicine (2020) 23:8 (548-556) Doi: 10.34172/Aim.2020.58), Archives of Iranian Medicine (2021)
120. Global, Regional and National Burden of Bladder Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, BMJ Global Health (2021)
121. Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Respiratory Medicine (2021)
122. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
123. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
124. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
125. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
126. Global, Regional, and National Progress Towards Sustainable Development Goal 3.2 for Neonatal and Child Health: All-Cause and Cause-Specific Mortality Findings From the Global Burden of Disease Study 2019, The Lancet (2021)
127. Global, Regional, and National Progress Towards Sustainable Development Goal 3.2 for Neonatal and Child Health: All-Cause and Cause-Specific Mortality Findings From the Global Burden of Disease Study 2019, The Lancet (2021)
128. Heterogeneous Contributions of Change in Population Distribution of Body Mass Index to Change in Obesity and Underweight, eLife (2021)
129. Heterogeneous Contributions of Change in Population Distribution of Body Mass Index to Change in Obesity and Underweight, eLife (2021)
130. Impact of 2017 Acc/Aha Guideline on Prevalence, Awareness, Treatment, Control, and Determinants of Hypertension: A Population-Based Cross-Sectional Study in Southwest of Iran, Population Health Metrics (2021)
131. Levels and Trends of Bmi, Obesity, and Overweight at National and Sub-National Levels in Iran From 1990 to 2016; a Comprehensive Pooled Analysis of Half a Million Individuals, Archives of Iranian Medicine (2021)
132. Levels and Trends of Hypertension at National and Subnational Scale in Iran From 1990 to 2016: A Systematic Review and Pooled Analysis, Archives of Iranian Medicine (2021)
133. Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data From Persian Cohort Study, Diabetes Therapy (2021)
134. Public Health Utility of Cause of Death Data: Applying Empirical Algorithms to Improve Data Quality, BMC Medical Informatics and Decision Making (2021)
135. Spatial, Temporal, and Demographic Patterns in Prevalence of Chewing Tobacco Use in 204 Countries and Territories, 1990-2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Public Health (2021)
136. Spatial, Temporal, and Demographic Patterns in Prevalence of Chewing Tobacco Use in 204 Countries and Territories, 1990-2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Public Health (2021)
137. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
138. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
139. Tracking Development Assistance for Health and for Covid-19: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 204 Countries and Territories, 1990–2050, The Lancet (2021)
140. Tracking Development Assistance for Health and for Covid-19: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 204 Countries and Territories, 1990–2050, The Lancet (2021)
141. Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control From 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies With 104 Million Participants, The Lancet (2021)
142. Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control From 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies With 104 Million Participants, The Lancet (2021)
143. Burden of Injury Along the Development Spectrum: Associations Between the Socio-Demographic Index and Disability-Adjusted Life Year Estimates From the Global Burden of Disease Study 2017, Injury Prevention (2020)
144. Effect of Storage Temperature and Time on Stability of Liver Enzymes in Blood Serum, Archives of Iranian Medicine (2020)
145. Effectiveness of Polypill for Prevention of Cardiovascular Disease (Polypars): Protocol of a Randomized Controlled Trial, Archives of Iranian Medicine (2020)
146. Epidemiology of Injuries From Fire, Heat and Hot Substances: Global, Regional and National Morbidity and Mortality Estimates From the Global Burden of Disease 2017 Study, Injury Prevention (2020)
147. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
148. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
149. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
150. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
151. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
152. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
153. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
154. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
155. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
156. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
157. Global Injury Morbidity and Mortality From 1990 to 2017: Results From the Global Burden of Disease Study 2017, Injury Prevention (2020)
158. Global Injury Morbidity and Mortality From 1990 to 2017: Results From the Global Burden of Disease Study 2017, Injury Prevention (2020)
159. Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
160. Habitual Dietary Intake of Flavonoids and All-Cause and Cause-Specific Mortality: Golestan Cohort Study, Nutrition Journal (2020)
161. Health Sector Spending and Spending on Hiv/Aids, Tuberculosis, and Malaria, and Development Assistance for Health: Progress Towards Sustainable Development Goal 3, The Lancet (2020)
162. Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study, Environmental Health Perspectives (2020)
163. Impaired Fasting Glucose and Major Adverse Cardiovascular Events by Hypertension and Dyslipidemia Status: The Golestan Cohort Study, BMC Cardiovascular Disorders (2020)
164. Mapping Child Growth Failure Across Low- and Middle-Income Countries, Nature (2020)
165. Mapping Disparities in Education Across Low- and Middle-Income Countries, Nature (2020)
166. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
167. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
168. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
169. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
170. Opium Use and Subsequent Incidence of Cancer: Results From the Golestan Cohort Study, The Lancet Global Health (2020)
171. Prevalence and Attributable Health Burden of Chronic Respiratory Diseases, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Respiratory Medicine (2020)
172. Repositioning of the Global Epicentre of Non-Optimal Cholesterol, Nature (2020)
173. Repositioning of the Global Epicentre of Non-Optimal Cholesterol, Nature (2020)
174. The Global, Regional, and National Burden of Cirrhosis by Cause in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
175. The Global, Regional, and National Burden of Gastro-Oesophageal Reflux Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
176. The Global, Regional, and National Burden of Inflammatory Bowel Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
177. The Global, Regional, and National Burden of Oesophageal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
178. The Global, Regional, and National Burden of Stomach Cancer in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
179. Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review, Middle East Journal of Digestive Diseases (2020)
180. Adherence to the Dietary Approaches to Stop Hypertension (Dash) Diet and Risk of Total and Cause-Specific Mortality: Results From the Golestan Cohort Study, International Journal of Epidemiology (2019)
181. Burden of Liver Diseases: A Review From Iran, Middle East Journal of Digestive Diseases (2019)
182. Burden of Neurodegenerative Diseases in the Eastern Mediterranean Region, 1990–2016: Findings From the Global Burden of Disease Study 2016, European Journal of Neurology (2019)
183. Comparing Anthropometric Indicators of Visceral and General Adiposity As Determinants of Overall and Cardiovascular Mortality, Archives of Iranian Medicine (2019)
184. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
185. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
186. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
187. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
188. Global, Regional, and National Burden of Stroke, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
189. Global, Regional, and National Burden of Suicide Mortality 1990 to 2016: Systematic Analysis for the Global Burden of Disease Study 2016, BMJ (Online) (2019)
190. Global, Regional, and National Burden of Traumatic Brain Injury and Spinal Cord Injury, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
191. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
192. Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980-2017, and Forecasts to 2030, for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, The Lancet HIV (2019)
193. Health Effects of Dietary Risks in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2019)
194. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
195. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
196. Past, Present, and Future of Global Health Financing: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 195 Countries, 1995-2050, The Lancet (2019)
197. Rising Rural Body-Mass Index Is the Main Driver of the Global Obesity Epidemic in Adults, Nature (2019)
198. Rising Rural Body-Mass Index Is the Main Driver of the Global Obesity Epidemic in Adults, Nature (2019)
199. The Application of Six Dietary Scores to a Middle Eastern Population: A Comparative Analysis of Mortality in a Prospective Study, European Journal of Epidemiology (2019)
200. The Burden of Headache Disorders in the Eastern Mediterranean Region, 1990-2016: Findings From the Global Burden of Disease Study 2016, Journal of Headache and Pain (2019)
201. The Global Burden of Non-Typhoidal Salmonella Invasive Disease: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Infectious Diseases (2019)
202. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
203. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
204. The Persian Guilan Cohort Study (Pgcs), Archives of Iranian Medicine (2019)
205. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)
206. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)
207. Burden of Diarrhea in the Eastern Mediterranean Region, 1990–2015: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
208. Burden of Obesity in the Eastern Mediterranean Region: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
209. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
210. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
211. Causes of Premature Death and Their Associated Risk Factors in the Golestan Cohort Study, Iran, BMJ Open (2018)
212. Contributions of Mean and Shape of Blood Pressure Distribution to Worldwide Trends and Variations in Raised Blood Pressure: A Pooled Analysis of 1018 Population-Based Measurement Studies With 88.6 Million Participants, International Journal of Epidemiology (2018)
213. Contributions of Mean and Shape of Blood Pressure Distribution to Worldwide Trends and Variations in Raised Blood Pressure: A Pooled Analysis of 1018 Population-Based Measurement Studies With 88.6 Million Participants, International Journal of Epidemiology (2018)
214. Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study, Archives of Iranian medicine (2018)
215. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
216. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
217. Global Mortality From Firearms, 1990-2016, JAMA - Journal of the American Medical Association (2018)
218. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
219. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
220. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
221. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
222. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 a Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2018)
223. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
224. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
225. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
226. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
227. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
228. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
229. Intentional Injuries in the Eastern Mediterranean Region, 1990–2015: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
230. Maternal Mortality and Morbidity Burden in the Eastern Mediterranean Region: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
231. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
232. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
233. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
234. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
235. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
236. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
237. Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study, Archives of Iranian Medicine (2018)
238. Spending on Health and Hiv/Aids: Domestic Health Spending and Development Assistance in 188 Countries, 1995–2015, The Lancet (2018)
239. The Burden of Cardiovascular Diseases Among Us States, 1990-2016, JAMA Cardiology (2018)
240. The Burden of Road Traffic Injuries in Iran and 15 Surrounding Countries: 1990–2016, Archives of Iranian Medicine (2018)
241. Trends in Hiv/Aids Morbidity and Mortality in Eastern Mediterranean Countries, 1990–2015: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)
242. Burden of Musculoskeletal Disorders in the Eastern Mediterranean Region, 1990-2013: Findings From the Global Burden of Disease Study 2013, Annals of the Rheumatic Diseases (2017)
243. Burden of Skin and Subcutaneous Diseases in Iran and Neighboring Countries: Results From the Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)
244. Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study, JAMA Pediatrics (2017)
245. Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study, American Journal of Epidemiology (2017)
246. Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran, American Journal of Preventive Medicine (2017)
247. Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale) in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)
248. Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran, Archives of Iranian Medicine (2017)
249. Erratum: Global, Regional, and National Levels of Maternal Mortality, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)), The Lancet (2017)
250. Erratum: Global, Regional, National, and Selected Subnational Levels of Stillbirths, Neonatal, Infant, and Under-5 Mortality, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)), The Lancet (2017)
251. Evolution and Patterns of Global Health Financing 1995-2014: Development Assistance for Health, and Government, Prepaid Private, and Out-Of-Pocket Health Spending in 184 Countries, The Lancet (2017)
252. Future and Potential Spending on Health 2015-40: Development Assistance for Health, and Government, Prepaid Private, and Out-Of-Pocket Health Spending in 184 Countries, The Lancet (2017)
253. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115Mmhg, 1990-2015, JAMA - Journal of the American Medical Association (2017)
254. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
255. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015, Journal of the American College of Cardiology (2017)
256. Global, Regional, and National Burden of Neurological Disorders During 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet Neurology (2017)
257. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2017)
258. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
259. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
260. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
261. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy, 1970-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
262. Health Effects of Overweight and Obesity in 195 Countries Over 25 Years, New England Journal of Medicine (2017)
263. Healthcare Access and Quality Index Based on Mortality From Causes Amenable to Personal Health Care in 195 Countries and Territories, 1990-2015: A Novel Analysis From the Global Burden of Disease Study 2015, The Lancet (2017)
264. Measuring Progress and Projecting Attainment on the Basis of Past Trends of the Health-Related Sustainable Development Goals in 188 Countries: An Analysis From the Global Burden of Disease Study 2016, The Lancet (2017)
265. Pars Cohort Study of Non-Communicable Diseases in Iran: Protocol and Preliminary Results, International Journal of Public Health (2017)
266. Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study, PLoS ONE (2017)
267. Prevalence and Years Lived With Disability of 310 Diseases and Injuries in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)
268. Smoking Prevalence and Attributable Disease Burden in 195 Countries and Territories, 1990-2015: A Systematic Analysis From the Global Burden of Disease Study 2015, The Lancet (2017)
269. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015, JAMA Oncology (2017)
270. Trend of Socio-Demographic Index and Mortality Estimates in Iran and Its Neighbors, 1990–2015; Findings of the Global Burden of Diseases 2015 Study, Archives of Iranian Medicine (2017)
271. Worldwide Trends in Blood Pressure From 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies With 19·1 Million Participants, The Lancet (2017)
272. Worldwide Trends in Blood Pressure From 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies With 19·1 Million Participants, The Lancet (2017)
273. Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults, The Lancet (2017)
274. Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults, The Lancet (2017)
275. A Century of Trends in Adult Human Height, eLife (2016)
276. A Century of Trends in Adult Human Height, eLife (2016)
277. Burden of Diarrhea in the Eastern Mediterranean Region, 1990-2013: Findings From the Global Burden of Disease Study 2013, American Journal of Tropical Medicine and Hygiene (2016)
278. Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-Wide Study From Iran, Archives of Iranian Medicine (2016)
279. Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-Wide Study From Iran, Archives of Iranian Medicine (2016)
280. Estimates of Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980–2015: The Global Burden of Disease Study 2015, The Lancet HIV (2016)
281. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013 Findings From the Global Burden of Disease 2013 Study, JAMA Pediatrics (2016)
282. Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
283. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
284. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 310 Diseases and Injuries, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
285. Global, Regional, and National Levels of Maternal Mortality, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
286. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
287. Global, Regional, National, and Selected Subnational Levels of Stillbirths, Neonatal, Infant, and Under-5 Mortality, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
288. Health in Times of Uncertainty in the Eastern Mediterranean Region, 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet Global Health (2016)
289. Hypertension and Mortality in the Golestan Cohort Study: A Prospective Study of 50 000 Adults in Iran, Journal of Human Hypertension (2016)
290. Measuring the Health-Related Sustainable Development Goals in 188 Countries: A Baseline Analysis From the Global Burden of Disease Study 2015, The Lancet (2016)
291. Reliability Analysis of a Newly Developed Questionnaire for Quality Control of Follow-Up Visits in Polyiran Study, Archives of Iranian Medicine (2016)
292. The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study, Archives of Iranian Medicine (2016)
293. The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study, Archives of Iranian Medicine (2016)
294. Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19.2 Million Participants, The Lancet (2016)
295. Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19.2 Million Participants, The Lancet (2016)
296. Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-Optimal Systolic Blood Pressure and Hypertension in Northeastern Iran, Archives of Iranian Medicine (2015)
297. Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)
298. Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)
299. Global, Regional, and National Disability-Adjusted Life Years (Dalys) for 306 Diseases and Injuries and Healthy Life Expectancy (Hale) for 188 Countries, 1990-2013: Quantifying the Epidemiological Transition, The Lancet (2015)
300. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)
301. The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran, PLoS ONE (2015)
302. The Global Burden of Cancer 2013, JAMA Oncology (2015)
303. Developing an Appropriate Model for Self-Care of Hypertensive Patients in Iran, ARYA Atherosclerosis (2013)